These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 8757945)

  • 21. Ameliorating effects of anti-Dll4 mAb on Theiler's murine encephalomyelitis virus-induced demyelinating disease.
    Takeichi N; Yanagisawa S; Kaneyama T; Yagita H; Jin YH; Kim BS; Koh CS
    Int Immunol; 2010 Sep; 22(9):729-38. PubMed ID: 20685674
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Suppression of Theiler's murine encephalomyelitis virus induced demyelinating disease by administration of gangliosides.
    Inoue A; Koh CS; Yanagisawa N; Taketomi T; Ishihara Y
    J Neuroimmunol; 1996 Jan; 64(1):45-53. PubMed ID: 8598389
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Paralysis caused by acute myelitis in Theiler's murine encephalomyelitis virus strain GD VII infection is induced by CD4+ lymphocytes infiltrating the spinal cord.
    Kohanawa M; Asano M; Min Y; Minagawa T; Nakane A
    J Gen Virol; 1995 Sep; 76 ( Pt 9)():2251-6. PubMed ID: 7561762
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of irradiation on development of Theiler's murine encephalomyelitis virus (TMEV)-induced demyelinating disease in genetically resistant mice.
    Pelka A; Olsberg C; Miller S; Waltenbaugh C; Creighton TM; dal Canto MC; Melvold R
    Cell Immunol; 1993 Dec; 152(2):440-55. PubMed ID: 8258150
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of Reported Spinal Cord Lesions in Progressive Multiple Sclerosis with Theiler's Murine Encephalomyelitis Virus Induced Demyelinating Disease.
    Leitzen E; Jin W; Herder V; Beineke A; Elmarabet SA; Baumgärtner W; Hansmann F
    Int J Mol Sci; 2019 Feb; 20(4):. PubMed ID: 30823515
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Flow cytometric and functional analyses of central nervous system-infiltrating cells in SJL/J mice with Theiler's virus-induced demyelinating disease. Evidence for a CD4+ T cell-mediated pathology.
    Pope JG; Karpus WJ; VanderLugt C; Miller SD
    J Immunol; 1996 May; 156(10):4050-8. PubMed ID: 8621948
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 5-Fluorouracil and levamisole exacerbate demyelination in susceptible mice infected with Theiler's virus.
    Lucchinetti CF; Kimmel DW; Pavelko K; Rodriguez M
    Exp Neurol; 1997 Sep; 147(1):123-9. PubMed ID: 9294409
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The predominant virus antigen burden is present in macrophages in Theiler's murine encephalomyelitis virus-induced demyelinating disease.
    Lipton HL; Twaddle G; Jelachich ML
    J Virol; 1995 Apr; 69(4):2525-33. PubMed ID: 7884902
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adoptively transferred CD8+ T lymphocytes provide protection against TMEV-induced demyelinating disease in BALB/c mice.
    Nicholson SM; Dal Canto MC; Miller SD; Melvold RW
    J Immunol; 1996 Feb; 156(3):1276-83. PubMed ID: 8558008
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Induction of the CXCL1 (KC) chemokine in mouse astrocytes by infection with the murine encephalomyelitis virus of Theiler.
    Rubio N; Sanz-Rodriguez F
    Virology; 2007 Feb; 358(1):98-108. PubMed ID: 16996102
    [TBL] [Abstract][Full Text] [Related]  

  • 31. N-Acetyl-cysteine inhibition of encephalomyelitis Theiler's virus-induced nitric oxide and tumour necrosis factor-alpha production by murine astrocyte cultures.
    Molina-Holgado F; Hernanz A; De la Fuente M; Guaza C
    Biofactors; 1999; 10(2-3):187-93. PubMed ID: 10609881
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transition from acute to persistent Theiler's virus infection requires active viral replication that drives proinflammatory cytokine expression and chronic demyelinating disease.
    Trottier M; Schlitt BP; Kung AY; Lipton HL
    J Virol; 2004 Nov; 78(22):12480-8. PubMed ID: 15507635
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prostaglandin E2 produced following infection with Theiler's virus promotes the pathogenesis of demyelinating disease.
    Kim SJ; Jin YH; Kim BS
    PLoS One; 2017; 12(4):e0176406. PubMed ID: 28445497
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of Theiler's Murine Encephalomyelitis Virus Induced Spinal Cord and Peripheral Nerve Lesions Following Intracerebral and Intraspinal Infection.
    Jin W; Leitzen E; Goebbels S; Nave KA; Baumgärtner W; Hansmann F
    Int J Mol Sci; 2019 Oct; 20(20):. PubMed ID: 31623261
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A hybrid between a resistant and a susceptible strain of mouse alters the pattern of Theiler's murine encephalomyelitis virus-induced white matter disease and favors oligodendrocyte-mediated remyelination.
    Dal Canto MC; Melvold RW; Kim BS
    Mult Scler; 1995 Jun; 1(2):95-103. PubMed ID: 9345459
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment with lipopolysaccharide enhances the pathogenicity of a low-pathogenic variant of Theiler's murine encephalomyelitis virus.
    Palma JP; Park SH; Kim BS
    J Neurosci Res; 1996 Sep; 45(6):776-85. PubMed ID: 8892089
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The level of viral infection of antigen-presenting cells correlates with the level of development of Theiler's murine encephalomyelitis virus-induced demyelinating disease.
    Jin YH; Kang HS; Hou W; Meng L; Kim BS
    J Virol; 2015 Feb; 89(3):1867-78. PubMed ID: 25428872
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Release of myelin basic protein-degrading proteolytic activity from microglia and macrophages after infection with Theiler's murine encephalomyelitis virus: comparison between susceptible and resistant mice.
    Liuzzi GM; Riccio P; Dal Canto MC
    J Neuroimmunol; 1995 Oct; 62(1):91-102. PubMed ID: 7499498
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of α4 integrin in Theiler's murine encephalomyelitis virus (TMEV)-induced demyelinating disease: an infectious animal model for multiple sclerosis (MS).
    Hirano Y; Kobayashi K; Tomiki H; Inaba Y; Ichikawa M; Kim BS; Koh CS
    Int Immunol; 2016 Dec; 28(12):575-584. PubMed ID: 27803063
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Therapeutic effect of anti-αv integrin mAb on Theiler's murine encephalomyelitis virus-induced demyelinating disease.
    Tomiki H; Kaneyama T; Kobayashi K; Inaba Y; Ichikawa M; Yagita H; Kim BS; Koh CS
    J Neuroimmunol; 2014 Mar; 268(1-2):25-34. PubMed ID: 24434077
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.